导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.49% | 3740/4982 |
| 近一周 | -3.33% | 4089/5419 |
| 近一月 | -2.30% | 1393/5423 |
| 近一季 | -9.63% | 2859/5358 |
| 近半年 | -7.00% | 3102/5131 |
| 近一年 | -10.80% | 3686/4733 |
| 近两年 | 16.63% | 3685/4208 |
| 近三年 | -1.63% | 3078/3661 |
| 成立以来 | 28.81% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.79% 4367/5130 |
15.54% 2354/5464 |
- - |
- - |
| 2025 | 6.06% 4162/5130 |
-3.58% 4374/4624 |
3.50% 1733/4802 |
9.65% 4057/4970 |
-3.07% 3004/5130 |
| 2024 | 14.36% 624/4618 |
1.13% 1102/4340 |
-0.67% 1598/4442 |
19.01% 363/4550 |
-4.34% 2933/4618 |
| 2023 | -22.40% 2888/4216 |
-0.52% 2493/3759 |
-6.06% 2555/3909 |
-6.87% 1797/4055 |
-10.82% 3840/4209 |
| 2022 | -26.66% 2028/3578 |
-14.61% 769/2804 |
4.63% 2114/3205 |
-13.43% 1969/3430 |
-5.17% 2639/3570 |
| 2021 | 8.71% 653/2717 |
-2.89% 752/1745 |
23.43% 234/2232 |
-8.22% 1575/2560 |
-1.18% 1737/2708 |
| 2020 | 57.36% 487/1596 |
-2.75% 592/1036 |
23.38% 563/1256 |
15.09% 324/1472 |
13.96% 712/1690 |
| 2019 | 58.59% 137/926 |
36.94% 132/3053 |
2.07% 481/3201 |
3.78% 586/939 |
9.33% 422/1014 |
| 2018 | -30.61% 434/668 |
- - |
- - |
-11.73% 2729/2970 |
-14.59% 2676/2975 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 0.9797 | 54.69% |
| 招商创新增长混合A | 1.0526 | 54.25% |
| 招商创新增长混合C | 1.0013 | 53.96% |
| 华泰柏瑞医疗健康A | 2.5834 | 49.29% |
| 招商品质成长混合A | 1.0196 | 49.15% |
| 大摩优悦安和混合A | 0.8851 | 47.23% |
| 大摩优悦安和混合C | 0.8688 | 47.08% |
| 华泰柏瑞医疗健康C | 2.5230 | 44.21% |
| 大摩健康产业混合A | 1.9140 | 32.70% |
| 中信建投医药健康A | 0.7640 | 31.75% |
| 银华估值优势混合 VS. 长安宏观策略混合A(740001) |